Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2)

被引:84
作者
Duan, XZ
Zhuang, H
Wang, M
Li, HW
Liu, JC
Wang, FS
机构
[1] Beijing 302 Hosp PLA, Beijing Inst Infect Dis, Res Ctr Biol Therapy, Beijing 100039, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China
关键词
chronic hepatitis B; dendritic cells; liver cirrhosis; subsets;
D O I
10.1111/j.1440-1746.2004.03529.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: To investigate the frequencies, numbers and function of circulating dendritic cell (DC) subsets in patients with hepatitis B virus (HBV) infection, we assayed the circulating precursor DC subsets (including pDC1 and pDC2) and their ability in patients at various stages of HBV infection in vitro. Methods: Circulating pDC1 and pDC2 frequencies in peripheral blood mononuclear cells (PBMC) were analyzed by flow cytometric analysis. Costimulatory molecule expression and allostimulatory mixed lymphocyte reaction (AMLR) of DC1, cultured from PBMC in vitro, were detected in patients with chronic hepatitis B (CHB). On behalf of pDC2, interferon (IFN)-alpha production of PBMC was determined by the ELISA method in HBV-infected patients. Results: The number of circulating pDC1 decreased only in patients with liver cirrhosis (LC) compared with that in normal controls. However, pDC2 numbers decreased in both CHB and LC patients. DC I from CHB patients showed lower expression of costimulatory molecules CD80, CD86 and impaired allostimulatory mixed lymphocyte reaction (AMLR) compared with those in normal controls. The ability of PBMC to secrete IFN-alpha. also decreased significantly in patients with chronic HBV infection. Conclusions: Our results suggest that patients with chronic HBV infection have a significantly lower expression of costimulatory molecules and impaired AMLR of pDC1, as well as decreased number and impaired function of circulating pDC2, which may be partially related to HBV disease progression in these patients. (C) 2004 Blackwell Publishing Asia Pry Ltd.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 28 条
[1]
Arima S, 2003, INT J MOL MED, V11, P169
[2]
Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation [J].
Arpinati, M ;
Chirumbolo, G ;
Urbini, B ;
Martelli, V ;
Stanzani, M ;
Falcioni, S ;
Bonifazi, F ;
Bandini, G ;
Tura, S ;
Baccarani, M ;
Rondelli, D .
BONE MARROW TRANSPLANTATION, 2002, 29 (11) :887-891
[3]
Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection [J].
Bain, C ;
Fatmi, A ;
Zoulim, F ;
Zarski, JP ;
Trépo, C ;
Inchauspé, G .
GASTROENTEROLOGY, 2001, 120 (02) :512-524
[4]
Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[5]
Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]
Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type I response in vitro:: mechanisms for viral immune escape [J].
Beckebaum, S ;
Cicinnati, VR ;
Zhang, X ;
Ferencik, S ;
Frilling, A ;
Grosse-Wilde, H ;
Broelsch, CE ;
Gerken, G .
IMMUNOLOGY, 2003, 109 (04) :487-495
[7]
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection [J].
Beckebaum, S ;
Cicinnati, VR ;
Dworacki, G ;
Müller-Berghaus, J ;
Stolz, D ;
Harnaha, J ;
Whiteside, TL ;
Thomson, AW ;
Lu, L ;
Fung, JJ ;
Bonham, CA .
CLINICAL IMMUNOLOGY, 2002, 104 (02) :138-150
[8]
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon [J].
Cella, M ;
Jarrossay, D ;
Facchetti, F ;
Alebardi, O ;
Nakajima, H ;
Lanzavecchia, A ;
Colonna, M .
NATURE MEDICINE, 1999, 5 (08) :919-923
[9]
Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis [J].
Chen, SR ;
Akbar, SMF ;
Tanimoto, K ;
Ninomiya, T ;
Iuchi, H ;
Michitaka, K ;
Horiike, N ;
Onji, M .
CANCER LETTERS, 2000, 148 (01) :49-57
[10]
The liver as a site of T-cell apoptosis: graveyard, or krilling field? [J].
Crispe, IN ;
Dao, T ;
Klugewitz, K ;
Mehal, WZ ;
Metz, DP .
IMMUNOLOGICAL REVIEWS, 2000, 174 :47-62